サンプル依頼リスト カート
  • English
  • Korean
表紙：子宮鏡検査の世界市場-2023年～2030年
市場調査レポート
商品コード
1347972

子宮鏡検査の世界市場-2023年～2030年

Global Hysteroscopy Market - 2023-2030
出版日: | 発行: DataM Intelligence | ページ情報: 英文 195 Pages | 納期: 約2営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
子宮鏡検査の世界市場-2023年～2030年
出版日: 2023年09月11日
発行: DataM Intelligence
ページ情報: 英文 195 Pages
納期: 約2営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

概要

子宮鏡検査は主に、子宮の異常出血、月経時の大量出血、月経と月経の間の不規則な点状出血、閉経後の出血などを引き起こす疾患の特定と治療に用いられます。この手術では、子宮鏡と呼ばれる器具を用いて子宮の内部を観察します。通常、病院または外来手術センターで行われ、全身麻酔または脊椎麻酔で行われます。

子宮鏡検査は、診断過程だけでなく治療過程の一部でもあります。診断的子宮鏡検査は、子宮の構造的な不整を特定し、超音波検査などの他の検査結果を確認するためにも用いられます。手術的子宮鏡検査は診断的子宮鏡検査で検出された異常を治療し、子宮内膜焼灼術は異常子宮出血を治療する一般的な処置です。

さらに、技術進歩の増加、製品の発売、投資の増加などの重要な成長促進要因が将来の市場成長をもたらします。Medtronic Plc.、Olympus Corporation、B. Braun Melsungen AG、Stryker Corporation、Hologic Inc.などの主要企業が、この市場で活発に活動しています。

ダイナミクス

子宮鏡検査機器の製品上市の増加

子宮鏡検査は、子宮頸部や子宮内部を検査するために膣内に挿入する細くて光の当たる管である子宮鏡を使用して行われます。大手企業による製品発売は市場成長の原動力となり、こうした効果的な研究開発は、何百万人もの婦人科疾患を持つ人々のケアを改善するための新しい診断、治療法の製品発売に役立っています。

例えば、2023年7月、GenWorks Health社は、子宮内組織の除去に簡単な機械的アプローチを使用する機械的子宮鏡組織除去システムを発売しました。これは低侵襲性のシステムで、より短時間で子宮内膜筋腫やポリープも完全に除去できることが実証されています。

さらに、2022年6月、UroViu Corporationは、UroViuのAlways Ready内視鏡プラットフォームと互換性のある単回使用子宮鏡、新しいHystero-Vを発売しました。Hystero-Vは12Frの半硬性で、親水性コーティングが施されており、優しい挿入と優れた可視化により、非常に効果的な子宮内検査を可能にします。従って、上記の要因により、予測期間中に市場は拡大すると予想されます。

子宮鏡検査への投資の増加

子宮鏡検査は、多くの子宮内および子宮頸管内問題の診断と治療に使用できる低侵襲的介入です。主要企業からの大規模な投資は市場成長を促進するのに役立ち、国家組織や企業からのこれらの効果的な資金は、研究発見を婦人科疾患の新しい診断や治療に変えるのに役立ちます。

例えば、2020年10月、Meditrina社は子宮内病変を治療するAvetaシステムを商品化するために1,300万米ドルを調達しました。Avetaシステムは、独自の拡張可能なワーキングチャンネル子宮鏡と、流体管理および切除システムを使用し、連続流下条件下で子宮鏡下組織片切除を行うように設計されています。

子宮鏡検査に伴う欠点が市場成長を妨げる

子宮鏡検査に関連する欠点には、子宮鏡検査装置や処置の高額な費用、発展途上国における訓練された専門家の不足、処置に伴う合併症や感染症のリスク、一部の地域における低侵襲処置に対する認識不足や消極的姿勢、子宮鏡検査装置の承認に関する厳しい規制、地方における高度ヘルスケア施設へのアクセスの制限などがあります。例えば米国では、子宮鏡検査の総費用は2,800米ドルから4,800米ドルの間です。したがって、これらの要因が市場の成長を制限しています。

目次

第1章 調査手法と調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

  • 影響要因
    • 促進要因
      • 子宮鏡検査機器の製品上市の増加
      • 子宮鏡検査への投資の増加
    • 抑制要因
      • 子宮鏡検査に伴う欠点
    • 機会
    • 影響分析

第5章 産業分析

  • ポーターのファイブフォース分析
  • サプライチェーン分析
  • アンメットニーズ
  • 規制分析
  • DMIの見解

第6章 COVID-19分析

第7章 製品別

  • 体液管理子宮鏡システム
  • 組織除去子宮鏡システム
  • ハンドヘルド子宮鏡システム
  • 子宮鏡
    • 軟性子宮鏡
    • 硬性子宮鏡
    • 接触型内視鏡
  • ヒステロシース
  • その他

第8章 用途別

  • 卵管避妊手術
  • 子宮摘出術
  • ポリペクトミー
  • 子宮筋腫核出術
  • 子宮内膜焼灼術
  • その他

第9章 エンドユーザー別

  • 病院
  • 外来手術センター
  • その他

第10章 地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • その他欧州
  • 南米
    • ブラジル
    • アルゼンチン
    • その他南米
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • オーストラリア
    • その他アジア太平洋
  • 中東・アフリカ

第11章 競合情勢

  • 競合シナリオ
  • 製品ベンチマーク
  • 企業シェア分析
  • 主な動向と戦略

第12章 企業プロファイル

  • Medtronic Plc.
    • 企業概要
    • 製品ポートフォリオと説明
    • 財務概要
    • 主な動向
  • Olympus Corporation
  • B. Braun Melsungen AG
  • Stryker Corporation
  • Hologic Inc.
  • CooperSurgical Inc.
  • XION GmbH
  • Richard Wolf GmbH
  • Karl Storz SE & Co.
  • Delmont Imaging

第13章 付録

目次
Product Code: MD1458

Overview

Hysteroscopy is primarily used to identify and treat conditions that cause abnormal uterine bleeding, heavy menstrual bleeding, irregular spotting between periods, and bleeding after menopause. The procedure allows the surgeon to look inside of uterus with a tool called a hysteroscope. It is typically performed in a hospital or outpatient surgical center and is usually done under general or spinal anesthesia.

Hysteroscopy can be a part of the diagnostic process, as well as the treatment process. Diagnostic hysteroscopy identifies structural irregularities in the uterus and also can be used to confirm the results of other tests such as an ultrasound. Operative hysteroscopy treats an abnormality detected during a diagnostic hysteroscopy and endometrial ablation is a common procedure that treats abnormal uterine bleeding.

Furthermore, significant growth drivers such as increasing technological advancements, product launches, and rising investments give rise to future market growth. Significant key players like Medtronic Plc., Olympus Corporation, B. Braun Melsungen AG, Stryker Corporation, Hologic Inc., and others are actively operating in the market.

Dynamics

Increasing Product Launches for Hysteroscopy Devices

Hysteroscopy is done using a hysteroscope which is a thin, lighted tube that is inserted into the vagina to examine the cervix and inside of the uterus. The product launches by major companies help to drive market growth and these effective research and developments help in product launches for new diagnoses, and treatments to improve care for millions of people with gynecological diseases.

For instance, in July 2023, GenWorks Health launched a mechanical hysteroscopic tissue removal system that uses a simple mechanical approach for removing intrauterine tissues. It is a minimally invasive system that has been demonstrated to be quicker and can also completely remove endometrial fibroids and polyps.

Additionally, in June 2022, UroViu Corporation launched the new Hystero-V, a single-use hysteroscope compatible with UroViu's Always Ready endoscopy platform. The 12-Fr, semi-rigid, Hystero-V features a hydrophilic coating enabling gentle insertion and superior visualization for highly effective intrauterine examinations. Hence, due to the above factors, the market is expected to boost over the forecast period.

Rising Investments in Hysteroscopy

Hysteroscopy is a minimally invasive intervention that can be used to diagnose and treat many intrauterine and endocervical problems. The major investments from key companies help to drive market growth and these effective funds from national organizations and companies help to transform research discoveries into new diagnoses and treatments for gynecology diseases.

For instance, in October 2020, Meditrina raised $13 million to commercialize the Aveta system for treating intrauterine pathologies. The Aveta system is designed to use a proprietary expandable working channel hysteroscope, along with a fluid management and resection system, for hysteroscopic tissue chip resection under continuous flow conditions

Drawbacks Associated with Hysteroscopy will Hamper the Market Growth

Drawbacks associated with hysteroscopy include the high cost of hysteroscopy devices and procedures, lack of trained professionals in developing countries, risk of complications and infections associated with the procedure, lack of awareness and reluctance towards minimally invasive procedures in some regions, stringent regulations for approval of hysteroscopy devices and limited access to advanced healthcare facilities in rural areas. For instance, in the United States, the total cost of hysteroscopy varies between $2800 and $4800. Hence, these factors are limiting the market growth.

Segment Analysis

The global hysteroscopy market is segmented based on product, application, end users, and region.

The use of mechanical tissue removal hysteroscopy systems is more frequently implemented as the first-line approach for the treatment of intrauterine pathology. Hysteroscopic tissue removal and retrieval is a procedure performed under local or general anesthesia that allows the doctor to check inside the uterus and remove any polyps or fibroids under direct vision. Tissue removal hysteroscopy systems are expected to hold the largest market share over the period forecast owing to increasing product launches and technical advancements.

For instance, in November 2022, Medtronic plc, launched the TruClear system, a mechanical hysteroscopic tissue removal system used for the safe and effective treatment of intrauterine abnormalities (IUA). TruClear is a next-generation device that provides practitioners with a clear operative field and patients with gentle mechanical resection during the procedure to help efficiently execute a hysteroscopy.

Additionally, in February 2021, VirtaMed launched a hysteroscopy and gynecological laparoscopy mixed tissue removal platform. VirtaMed's hysteroscopy system has been updated to include 16 cases for MyoSure tissue removal, added to over 50 cases in diagnostics, polypectomy, myomectomy, and tissue ablation. Hence, the above factors help to accelerate the market growth.

Geographical Penetration

North America Accounted for Approximately 38.4% of the Market Share in 2022

The global hysteroscopy market is segmented into North America, Europe, Asia Pacific, South America, Middle East, and Africa. North America has maintained a significant proportion of the hysteroscopy market in recent years, and this trend is anticipated to continue throughout the forecast period due to factors such as the rising prevalence and incidence of hysterectomy, and product launches in hysteroscopy devices.

For instance, according to the Centers for Disease Control and Prevention,2022, it states that hysterectomy is the second most common surgical procedure for women and approximately 600,000 hysterectomies are performed in the United States each year. Additionally, From 2012 to 2020, the age-standardized hysterectomy prevalence among adult U.S. women was 17.9%. It steadily increased with each consecutive age group and was highest among women aged more than 80 years (48.8%).

Furthermore, in December 2020, Hologic, Inc. launched its Omni hysteroscope which is an innovative three-in-one modular scope with advanced visualization capabilities designed for both diagnostic and therapeutic hysteroscopic procedures. The Omni scope, which received 510(k) clearance from the U.S. Food and Drug Administration (FDA) is designed to help physicians streamline the process of diagnosing and treating patients

Competitive Landscape

The major global players in the market include: Medtronic Plc., Olympus Corporation, B. Braun Melsungen AG, Stryker Corporation, Hologic Inc., CooperSurgical Inc., XION GmbH, Richard Wolf GmbH, Karl Storz SE & Co., Delmont Imaging among others.

COVID-19 Impact Analysis

The COVID-19 pandemic has had a significant impact on the global hysteroscopy market. The onset of the pandemic in early 2020 led to widespread lockdowns and restrictions, impacting regular check-ups, appointments, device launches, and consultations worldwide. Many hospitals are focused on COVID-19 cases, and this reduces the diagnosis of many patients suffering from various gynecology and obstetrics disorders.

Moreover, the focus of research and development efforts shifted during the pandemic, with a significant emphasis on developing vaccines and treatments for COVID-19. Therefore, owing to the above factors, the hysteroscopy market is expected to be moderately affected over the forecast period.

By Product

  • Fluid Management Hysteroscopy Systems
  • Tissue Removal Hysteroscopy Systems
  • Hand-held Hysteroscopy Systems
  • Hysteroscopes
    • Flexible hysteroscopes
    • Rigid hysteroscopes
  • Contact hysteroscopes
    • Hysterosheaths
    • Others

By Application

  • Tubal Sterilization
  • Hysterectomy
  • Polypectomy
  • Myomectomy
  • Endometrial Ablation
  • Others

By End Users

  • Hospitals
  • Ambulatory Surgical Centers
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Rest of Europe
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • Rest of Asia-Pacific
  • Middle East and Africa

Key Developments

  • In October 2022, UroViu Corporation secured a medical equipment ECAT contract for VA DoD Purchasing. The single-use platform ranges from a 12-Fr diagnostic semi-rigid cystoscope and equivalent hysteroscope, a 14-Fr injection cystoscope with an integrated needle for drug delivery, to a flexible, deflectable, and rotatable 16.5-Fr cystoscope.
  • In October 2021, Hologic, Inc. launched an expanded Omni suite, a comprehensive gynecological surgical offering. The expanded Omni suite aims to optimize diagnostic and operative hysteroscopy in Europe, Africa, and the Middle East (EMEA). The expanded offering includes the Omni 30° hysteroscope, Omni Lok cervical seal, and Omni 5 French seal.

Why Purchase the Report?

  • To visualize the global hysteroscopy market segmentation based on product, application, end users, and region, as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of global hysteroscopy market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as excel consisting of key products of all the major players.

The global hysteroscopy market report would provide approximately 69 tables, 70 figures, and 195 Pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Product
  • 3.2. Snippet by Application
  • 3.3. Snippet by End Users
  • 3.4. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increasing Product Launches for Hysteroscopy Devices
      • 4.1.1.2. Rising Investments in Hysteroscopy
    • 4.1.2. Restraints
      • 4.1.2.1. Drawbacks Associated with Hysteroscopy
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's 5 Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Unmet Needs
  • 5.4. Regulatory Analysis
  • 5.5. DMI Opinion

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Scenario Before COVID-19
    • 6.1.2. Scenario During COVID-19
    • 6.1.3. Scenario Post COVID-19
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During the Pandemic
  • 6.5. Manufacturers' Strategic Initiatives
  • 6.6. Conclusion

7. By Product

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 7.1.2. Market Attractiveness Index, By Product
  • 7.2. Fluid Management Hysteroscopy Systems
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Tissue Removal Hysteroscopy Systems
  • 7.4. Hand-held Hysteroscopy Systems
  • 7.5. Hysteroscopes
    • 7.5.1. Flexible hysteroscopes
    • 7.5.2. Rigid hysteroscopes
    • 7.5.3. Contact hysteroscopes
  • 7.6. Hysterosheaths
  • 7.7. Others

8. By Application

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.1.2. Market Attractiveness Index, By Application
  • 8.2. Tubal Sterilization
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Hysterectomy
  • 8.4. Polypectomy
  • 8.5. Myomectomy
  • 8.6. Endometrial Ablation
  • 8.7. Others

9. By End Users

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End Users
    • 9.1.2. Market Attractiveness Index, By End Users
  • 9.2. Hospitals
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Ambulatory Surgical Centers
  • 9.4. Others

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 10.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Applications
    • 10.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End Users
    • 10.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1. U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 10.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Applications
    • 10.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End Users
    • 10.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.3.6.1. Germany
      • 10.3.6.2. U.K.
      • 10.3.6.3. France
      • 10.3.6.4. Italy
      • 10.3.6.5. Spain
      • 10.3.6.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 10.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Applications
    • 10.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End Users
    • 10.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. Brazil
      • 10.4.6.2. Argentina
      • 10.4.6.3. Rest of South America
  • 10.5. Asia Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 10.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Applications
    • 10.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End Users
    • 10.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. China
      • 10.5.6.2. India
      • 10.5.6.3. Japan
      • 10.5.6.4. Australia
      • 10.5.6.5. Rest of Asia Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 10.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Applications
    • 10.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End Users

11. Competitive Landscape

  • 11.1. Competitive Scenario
  • 11.2. Product Benchmarking
  • 11.3. Company Share Analysis
  • 11.4. Key Developments and Strategies

12. Company Profiles

  • 12.1. Medtronic Plc.*
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Financial Overview
    • 12.1.4. Key Developments
  • 12.2. Olympus Corporation
  • 12.3. B. Braun Melsungen AG
  • 12.4. Stryker Corporation
  • 12.5. Hologic Inc.
  • 12.6. CooperSurgical Inc.
  • 12.7. XION GmbH
  • 12.8. Richard Wolf GmbH
  • 12.9. Karl Storz SE & Co.
  • 12.10. Delmont Imaging

LIST NOT EXHAUSTIVE

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us